Clinical Trial Update: Chidamide for Patients With Recurrent and Metastatic Epstein-Barr Virus (EBV)-Associated Solid Tumors [Phase 2]

View source ↗

Summary

This clinical trial update describes a Phase 2 study of chidamide in patients with recurrent and metastatic Epstein-Barr virus–associated solid tumors.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epstein-barr Virus-associated Solid Tumors

Drugs mentioned

• Chidamide (chidamide)

Snippet

Sponsor: Sun Yat-sen University | Conditions: Experimental Tumor | Phase 2 | Status: UNKNOWN